ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

Bills To Lift $50 Cap On Mammography Will Be Introduced

February 10, 1989

Vogel To Succeed Yates As VP for Research At American Cancer Society.

October 17, 2008

DoD Ovarian Cancer Research Program seeks proposals for FY05 funding.

October 1, 2004

NCI Forms Lung Cancer Program for Research On Early Detection, Treatment.

June 23, 2006